- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Antibody market size is estimated to be worth US$ 9354.2 million in 2021 and is forecast to a readjusted size of USD 13230 million by 2028 with a CAGR of 5.1% during review period. Therapeutic accounting for % of the Antibody global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While IgM segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Antibody include Roche, Johnson and Johnson, Merck, Novartis, and AbbVie, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antibody market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
IgM
IgG
IgA
Other
Market segment by Application can be divided into
Therapeutic
Research
Diagnostic
The key market players for global Antibody market are listed below:
Roche
Johnson and Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibody product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antibody, with price, sales, revenue and global market share of Antibody from 2019 to 2022.
Chapter 3, the Antibody competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibody breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Antibody market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody.
Chapter 13, 14, and 15, to describe Antibody sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Antibody Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antibody Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 IgM
1.2.3 IgG
1.2.4 IgA
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Antibody Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Therapeutic
1.3.3 Research
1.3.4 Diagnostic
1.4 Global Antibody Market Size & Forecast
1.4.1 Global Antibody Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Antibody Sales in Volume (2017-2028)
1.4.3 Global Antibody Price (2017-2028)
1.5 Global Antibody Production Capacity Analysis
1.5.1 Global Antibody Total Production Capacity (2017-2028)
1.5.2 Global Antibody Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antibody Market Drivers
1.6.2 Antibody Market Restraints
1.6.3 Antibody Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Antibody Product and Services
2.1.4 Roche Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Johnson and Johnson
2.2.1 Johnson and Johnson Details
2.2.2 Johnson and Johnson Major Business
2.2.3 Johnson and Johnson Antibody Product and Services
2.2.4 Johnson and Johnson Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Antibody Product and Services
2.3.4 Merck Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Antibody Product and Services
2.4.4 Novartis Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business
2.5.3 AbbVie Antibody Product and Services
2.5.4 AbbVie Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Antibody Product and Services
2.6.4 Amgen Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Antibody Product and Services
2.7.4 Pfizer Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business
2.8.3 Bayer Antibody Product and Services
2.8.4 Bayer Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Lilly
2.9.1 Lilly Details
2.9.2 Lilly Major Business
2.9.3 Lilly Antibody Product and Services
2.9.4 Lilly Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Bristol-Myers Squibb
2.10.1 Bristol-Myers Squibb Details
2.10.2 Bristol-Myers Squibb Major Business
2.10.3 Bristol-Myers Squibb Antibody Product and Services
2.10.4 Bristol-Myers Squibb Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business
2.11.3 GlaxoSmithKline Antibody Product and Services
2.11.4 GlaxoSmithKline Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Biogen
2.12.1 Biogen Details
2.12.2 Biogen Major Business
2.12.3 Biogen Antibody Product and Services
2.12.4 Biogen Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 AstraZeneca
2.13.1 AstraZeneca Details
2.13.2 AstraZeneca Major Business
2.13.3 AstraZeneca Antibody Product and Services
2.13.4 AstraZeneca Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Sanofi
2.14.1 Sanofi Details
2.14.2 Sanofi Major Business
2.14.3 Sanofi Antibody Product and Services
2.14.4 Sanofi Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Alexion Pharmaceuticals
2.15.1 Alexion Pharmaceuticals Details
2.15.2 Alexion Pharmaceuticals Major Business
2.15.3 Alexion Pharmaceuticals Antibody Product and Services
2.15.4 Alexion Pharmaceuticals Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Seattle Genetics
2.16.1 Seattle Genetics Details
2.16.2 Seattle Genetics Major Business
2.16.3 Seattle Genetics Antibody Product and Services
2.16.4 Seattle Genetics Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Antibody Breakdown Data by Manufacturer
3.1 Global Antibody Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Antibody Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Antibody
3.4 Market Concentration Rate
3.4.1 Top 3 Antibody Manufacturer Market Share in 2021
3.4.2 Top 6 Antibody Manufacturer Market Share in 2021
3.5 Global Antibody Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Antibody Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antibody Market Size by Region
4.1.1 Global Antibody Sales in Volume by Region (2017-2028)
4.1.2 Global Antibody Revenue by Region (2017-2028)
4.2 North America Antibody Revenue (2017-2028)
4.3 Europe Antibody Revenue (2017-2028)
4.4 Asia-Pacific Antibody Revenue (2017-2028)
4.5 South America Antibody Revenue (2017-2028)
4.6 Middle East and Africa Antibody Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Antibody Sales in Volume by Type (2017-2028)
5.2 Global Antibody Revenue by Type (2017-2028)
5.3 Global Antibody Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Antibody Sales in Volume by Application (2017-2028)
6.2 Global Antibody Revenue by Application (2017-2028)
6.3 Global Antibody Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Antibody Sales by Type (2017-2028)
7.2 North America Antibody Sales by Application (2017-2028)
7.3 North America Antibody Market Size by Country
7.3.1 North America Antibody Sales in Volume by Country (2017-2028)
7.3.2 North America Antibody Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Antibody Sales by Type (2017-2028)
8.2 Europe Antibody Sales by Application (2017-2028)
8.3 Europe Antibody Market Size by Country
8.3.1 Europe Antibody Sales in Volume by Country (2017-2028)
8.3.2 Europe Antibody Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Antibody Sales by Type (2017-2028)
9.2 Asia-Pacific Antibody Sales by Application (2017-2028)
9.3 Asia-Pacific Antibody Market Size by Region
9.3.1 Asia-Pacific Antibody Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Antibody Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Antibody Sales by Type (2017-2028)
10.2 South America Antibody Sales by Application (2017-2028)
10.3 South America Antibody Market Size by Country
10.3.1 South America Antibody Sales in Volume by Country (2017-2028)
10.3.2 South America Antibody Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antibody Sales by Type (2017-2028)
11.2 Middle East & Africa Antibody Sales by Application (2017-2028)
11.3 Middle East & Africa Antibody Market Size by Country
11.3.1 Middle East & Africa Antibody Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Antibody Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Antibody and Key Manufacturers
12.2 Manufacturing Costs Percentage of Antibody
12.3 Antibody Production Process
12.4 Antibody Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Antibody Typical Distributors
13.3 Antibody Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Antibody Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Antibody Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Antibody Product and Services
Table 6. Roche Antibody Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson and Johnson Major Business
Table 9. Johnson and Johnson Antibody Product and Services
Table 10. Johnson and Johnson Antibody Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Antibody Product and Services
Table 14. Merck Antibody Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Novartis Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Major Business
Table 17. Novartis Antibody Product and Services
Table 18. Novartis Antibody Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. AbbVie Basic Information, Manufacturing Base and Competitors
Table 20. AbbVie Major Business
Table 21. AbbVie Antibody Product and Services
Table 22. AbbVie Antibody Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Amgen Basic Information, Manufacturing Base and Competitors
Table 24. Amgen Major Business
Table 25. Amgen Antibody Product and Services
Table 26. Amgen Antibody Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Pfizer Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer Major Business
Table 29. Pfizer Antibody Product and Services
Table 30. Pfizer Antibody Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Bayer Basic Information, Manufacturing Base and Competitors
Table 32. Bayer Major Business
Table 33. Bayer Antibody Product and Services
Table 34. Bayer Antibody Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Lilly Basic Information, Manufacturing Base and Competitors
Table 36. Lilly Major Business
Table 37. Lilly Antibody Product and Services
Table 38. Lilly Antibody Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 40. Bristol-Myers Squibb Major Business
Table 41. Bristol-Myers Squibb Antibody Product and Services
Table 42. Bristol-Myers Squibb Antibody Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline Major Business
Table 45. GlaxoSmithKline Antibody Product and Services
Table 46. GlaxoSmithKline Antibody Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Biogen Basic Information, Manufacturing Base and Competitors
Table 48. Biogen Major Business
Table 49. Biogen Antibody Product and Services
Table 50. Biogen Antibody Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 52. AstraZeneca Major Business
Table 53. AstraZeneca Antibody Product and Services
Table 54. AstraZeneca Antibody Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Sanofi Basic Information, Manufacturing Base and Competitors
Table 56. Sanofi Major Business
Table 57. Sanofi Antibody Product and Services
Table 58. Sanofi Antibody Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Alexion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Alexion Pharmaceuticals Major Business
Table 61. Alexion Pharmaceuticals Antibody Product and Services
Table 62. Alexion Pharmaceuticals Antibody Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Seattle Genetics Basic Information, Manufacturing Base and Competitors
Table 64. Seattle Genetics Major Business
Table 65. Seattle Genetics Antibody Product and Services
Table 66. Seattle Genetics Antibody Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Global Antibody Sales by Manufacturer (2019, 2020, 2021, and 2022) & (KG)
Table 68. Global Antibody Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 69. Market Position of Manufacturers in Antibody, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 70. Global Antibody Production Capacity by Company, (KG): 2020 VS 2021
Table 71. Head Office and Antibody Production Site of Key Manufacturer
Table 72. Antibody New Entrant and Capacity Expansion Plans
Table 73. Antibody Mergers & Acquisitions in the Past Five Years
Table 74. Global Antibody Sales by Region (2017-2022) & (KG)
Table 75. Global Antibody Sales by Region (2023-2028) & (KG)
Table 76. Global Antibody Revenue by Region (2017-2022) & (USD Million)
Table 77. Global Antibody Revenue by Region (2023-2028) & (USD Million)
Table 78. Global Antibody Sales by Type (2017-2022) & (KG)
Table 79. Global Antibody Sales by Type (2023-2028) & (KG)
Table 80. Global Antibody Revenue by Type (2017-2022) & (USD Million)
Table 81. Global Antibody Revenue by Type (2023-2028) & (USD Million)
Table 82. Global Antibody Price by Type (2017-2022) & (USD/KG)
Table 83. Global Antibody Price by Type (2023-2028) & (USD/KG)
Table 84. Global Antibody Sales by Application (2017-2022) & (KG)
Table 85. Global Antibody Sales by Application (2023-2028) & (KG)
Table 86. Global Antibody Revenue by Application (2017-2022) & (USD Million)
Table 87. Global Antibody Revenue by Application (2023-2028) & (USD Million)
Table 88. Global Antibody Price by Application (2017-2022) & (USD/KG)
Table 89. Global Antibody Price by Application (2023-2028) & (USD/KG)
Table 90. North America Antibody Sales by Country (2017-2022) & (KG)
Table 91. North America Antibody Sales by Country (2023-2028) & (KG)
Table 92. North America Antibody Revenue by Country (2017-2022) & (USD Million)
Table 93. North America Antibody Revenue by Country (2023-2028) & (USD Million)
Table 94. North America Antibody Sales by Type (2017-2022) & (KG)
Table 95. North America Antibody Sales by Type (2023-2028) & (KG)
Table 96. North America Antibody Sales by Application (2017-2022) & (KG)
Table 97. North America Antibody Sales by Application (2023-2028) & (KG)
Table 98. Europe Antibody Sales by Country (2017-2022) & (KG)
Table 99. Europe Antibody Sales by Country (2023-2028) & (KG)
Table 100. Europe Antibody Revenue by Country (2017-2022) & (USD Million)
Table 101. Europe Antibody Revenue by Country (2023-2028) & (USD Million)
Table 102. Europe Antibody Sales by Type (2017-2022) & (KG)
Table 103. Europe Antibody Sales by Type (2023-2028) & (KG)
Table 104. Europe Antibody Sales by Application (2017-2022) & (KG)
Table 105. Europe Antibody Sales by Application (2023-2028) & (KG)
Table 106. Asia-Pacific Antibody Sales by Region (2017-2022) & (KG)
Table 107. Asia-Pacific Antibody Sales by Region (2023-2028) & (KG)
Table 108. Asia-Pacific Antibody Revenue by Region (2017-2022) & (USD Million)
Table 109. Asia-Pacific Antibody Revenue by Region (2023-2028) & (USD Million)
Table 110. Asia-Pacific Antibody Sales by Type (2017-2022) & (KG)
Table 111. Asia-Pacific Antibody Sales by Type (2023-2028) & (KG)
Table 112. Asia-Pacific Antibody Sales by Application (2017-2022) & (KG)
Table 113. Asia-Pacific Antibody Sales by Application (2023-2028) & (KG)
Table 114. South America Antibody Sales by Country (2017-2022) & (KG)
Table 115. South America Antibody Sales by Country (2023-2028) & (KG)
Table 116. South America Antibody Revenue by Country (2017-2022) & (USD Million)
Table 117. South America Antibody Revenue by Country (2023-2028) & (USD Million)
Table 118. South America Antibody Sales by Type (2017-2022) & (KG)
Table 119. South America Antibody Sales by Type (2023-2028) & (KG)
Table 120. South America Antibody Sales by Application (2017-2022) & (KG)
Table 121. South America Antibody Sales by Application (2023-2028) & (KG)
Table 122. Middle East & Africa Antibody Sales by Region (2017-2022) & (KG)
Table 123. Middle East & Africa Antibody Sales by Region (2023-2028) & (KG)
Table 124. Middle East & Africa Antibody Revenue by Region (2017-2022) & (USD Million)
Table 125. Middle East & Africa Antibody Revenue by Region (2023-2028) & (USD Million)
Table 126. Middle East & Africa Antibody Sales by Type (2017-2022) & (KG)
Table 127. Middle East & Africa Antibody Sales by Type (2023-2028) & (KG)
Table 128. Middle East & Africa Antibody Sales by Application (2017-2022) & (KG)
Table 129. Middle East & Africa Antibody Sales by Application (2023-2028) & (KG)
Table 130. Antibody Raw Material
Table 131. Key Manufacturers of Antibody Raw Materials
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Antibody Typical Distributors
Table 135. Antibody Typical Customers
List of Figures
Figure 1. Antibody Picture
Figure 2. Global Antibody Revenue Market Share by Type in 2021
Figure 3. IgM
Figure 4. IgG
Figure 5. IgA
Figure 6. Other
Figure 7. Global Antibody Revenue Market Share by Application in 2021
Figure 8. Therapeutic
Figure 9. Research
Figure 10. Diagnostic
Figure 11. Global Antibody Revenue, (USD Million) & (KG): 2017 & 2021 & 2028
Figure 12. Global Antibody Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Antibody Sales (2017-2028) & (KG)
Figure 14. Global Antibody Price (2017-2028) & (USD/KG)
Figure 15. Global Antibody Production Capacity (2017-2028) & (KG)
Figure 16. Global Antibody Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Antibody Market Drivers
Figure 18. Antibody Market Restraints
Figure 19. Antibody Market Trends
Figure 20. Global Antibody Sales Market Share by Manufacturer in 2021
Figure 21. Global Antibody Revenue Market Share by Manufacturer in 2021
Figure 22. Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Antibody Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Antibody Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Antibody Sales Market Share by Region (2017-2028)
Figure 26. Global Antibody Revenue Market Share by Region (2017-2028)
Figure 27. North America Antibody Revenue (2017-2028) & (USD Million)
Figure 28. Europe Antibody Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Antibody Revenue (2017-2028) & (USD Million)
Figure 30. South America Antibody Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Antibody Revenue (2017-2028) & (USD Million)
Figure 32. Global Antibody Sales Market Share by Type (2017-2028)
Figure 33. Global Antibody Revenue Market Share by Type (2017-2028)
Figure 34. Global Antibody Price by Type (2017-2028) & (USD/KG)
Figure 35. Global Antibody Sales Market Share by Application (2017-2028)
Figure 36. Global Antibody Revenue Market Share by Application (2017-2028)
Figure 37. Global Antibody Price by Application (2017-2028) & (USD/KG)
Figure 38. North America Antibody Sales Market Share by Type (2017-2028)
Figure 39. North America Antibody Sales Market Share by Application (2017-2028)
Figure 40. North America Antibody Sales Market Share by Country (2017-2028)
Figure 41. North America Antibody Revenue Market Share by Country (2017-2028)
Figure 42. United States Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Antibody Sales Market Share by Type (2017-2028)
Figure 46. Europe Antibody Sales Market Share by Application (2017-2028)
Figure 47. Europe Antibody Sales Market Share by Country (2017-2028)
Figure 48. Europe Antibody Revenue Market Share by Country (2017-2028)
Figure 49. Germany Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Antibody Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Antibody Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Antibody Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Antibody Revenue Market Share by Region (2017-2028)
Figure 58. China Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Antibody Sales Market Share by Type (2017-2028)
Figure 65. South America Antibody Sales Market Share by Application (2017-2028)
Figure 66. South America Antibody Sales Market Share by Country (2017-2028)
Figure 67. South America Antibody Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Antibody Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Antibody Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Antibody Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Antibody Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Antibody in 2021
Figure 79. Manufacturing Process Analysis of Antibody
Figure 80. Antibody Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
